• Je něco špatně v tomto záznamu ?

Frequency of mutations associated with resistance to first- and second-line drugs in multidrug-resistant Mycobacterium tuberculosis isolates

I. Bitar, M. Medvecky, J. Amlerova, CC. Papagiannitsis, J. Hrabak

. 2020 ; 22 (-) : 275-282. [pub] 20200401

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21020199

Grantová podpora
NV17-29239A MZ0 CEP - Centrální evidence projektů

INTRODUCTION: Tuberculosis is considered one of the most fatal diseases worldwide, with an estimation of 10.1 million cases. In this study, whole-genome sequencing was used to determine the genomic characterisation of 40 Mycobacterium tuberculosis isolates from patients with different nationalities hospitalised in the Czech Republic. MATERIALS AND METHODS: Susceptibility testing for first-line drugs was performed. DNA was sequenced using the Illumina MiSeq platform. Spoligotype single-nucleotide polymorphisms and mutations in antibiotic-resistant genes were detected, and phylogenetic analysis was performed. RESULTS: Samples showing phenotypic resistance to at least one drug were 12 to streptomycin, 11 to isoniazid, 7 to rifampicin, 6 to ethambutol and 5 to pyrazinamide. Phenotypic and genotypic profiles did not match in all cases, suggesting the presence of a novel mutation in some cases and a low expression of resistant genes in others. The presented phylogeny enables the correct assignation of M. tuberculosis lineages and sublineages. Our results suggest that the most dominant lineage in our samples was lineage 4 (33/40). CONCLUSION: To our knowledge, this is the first study using this approach to be done in the Czech Republic. Lineage 4 was the predominant lineage identified among our samples. Nevertheless, the dominance of Lineage 4 along with other lineages suggests that infections can originate from different sources.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21020199
003      
CZ-PrNML
005      
20210830101828.0
007      
ta
008      
210728s2020 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jgar.2020.03.013 $2 doi
035    __
$a (PubMed)32247078
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Bitar, Ibrahim $u Department of Microbiology, Faculty of Medicine in Pilsen, Charles University, Plzen, Czech Republic; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Plzen, Czech Republic. Electronic address: ibrahimbitar5@gmail.com
245    10
$a Frequency of mutations associated with resistance to first- and second-line drugs in multidrug-resistant Mycobacterium tuberculosis isolates / $c I. Bitar, M. Medvecky, J. Amlerova, CC. Papagiannitsis, J. Hrabak
520    9_
$a INTRODUCTION: Tuberculosis is considered one of the most fatal diseases worldwide, with an estimation of 10.1 million cases. In this study, whole-genome sequencing was used to determine the genomic characterisation of 40 Mycobacterium tuberculosis isolates from patients with different nationalities hospitalised in the Czech Republic. MATERIALS AND METHODS: Susceptibility testing for first-line drugs was performed. DNA was sequenced using the Illumina MiSeq platform. Spoligotype single-nucleotide polymorphisms and mutations in antibiotic-resistant genes were detected, and phylogenetic analysis was performed. RESULTS: Samples showing phenotypic resistance to at least one drug were 12 to streptomycin, 11 to isoniazid, 7 to rifampicin, 6 to ethambutol and 5 to pyrazinamide. Phenotypic and genotypic profiles did not match in all cases, suggesting the presence of a novel mutation in some cases and a low expression of resistant genes in others. The presented phylogeny enables the correct assignation of M. tuberculosis lineages and sublineages. Our results suggest that the most dominant lineage in our samples was lineage 4 (33/40). CONCLUSION: To our knowledge, this is the first study using this approach to be done in the Czech Republic. Lineage 4 was the predominant lineage identified among our samples. Nevertheless, the dominance of Lineage 4 along with other lineages suggests that infections can originate from different sources.
650    12
$a antituberkulotika $x farmakologie $7 D000995
650    12
$a mnohočetná bakteriální léková rezistence $x genetika $7 D024901
650    _2
$a lidé $7 D006801
650    _2
$a mutace $7 D009154
650    12
$a Mycobacterium tuberculosis $x genetika $7 D009169
650    _2
$a fylogeneze $7 D010802
650    12
$a multirezistentní tuberkulóza $7 D018088
651    _2
$a Česká republika $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Medvecky, Matej $u Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Plzen, Czech Republic; CEITEC VFU, University of Veterinary and Pharmaceutical Sciences Brno, Brno, Czech Republic
700    1_
$a Amlerova, Jana $u Department of Microbiology, Faculty of Medicine in Pilsen, Charles University, Plzen, Czech Republic; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Plzen, Czech Republic
700    1_
$a Papagiannitsis, Costas C $u Department of Microbiology, Faculty of Medicine in Pilsen, Charles University, Plzen, Czech Republic; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Plzen, Czech Republic
700    1_
$a Hrabak, Jaroslav $u Department of Microbiology, Faculty of Medicine in Pilsen, Charles University, Plzen, Czech Republic; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Plzen, Czech Republic
773    0_
$w MED00198738 $t Journal of global antimicrobial resistance $x 2213-7173 $g Roč. 22, č. - (2020), s. 275-282
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32247078 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830101828 $b ABA008
999    __
$a ok $b bmc $g 1690901 $s 1140645
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 22 $c - $d 275-282 $e 20200401 $i 2213-7173 $m Journal of global antimicrobial resistance (Print) $n J Glob Antimicrob Resist $x MED00198738
GRA    __
$a NV17-29239A $p MZ0
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Možnosti archivace